A members-only intelligence terminal for the longevity economy.
It continuously synthesises the research, trial, regulatory and corporate record across the field into one structured dashboard — refreshed every month.
The month's decisive moves, each with a plain-language note on why it matters.
Every financing, M&A, IPO and pricing shift across all categories — because capital moves before the clinical evidence does.
A commercial read for clinics and med-spas: demand × regulatory friction × hype.
Leaderboards, momentum, the developments & approvals timeline, active sponsors, and a "buzz vs. science" comparison.
The US plus China, Japan, Korea, Australia/NZ, Europe and the Middle East.
Sizing the market and spotting where capital is moving first.
Tracking the field across compounds, trials and sponsors.
Deciding what to offer, and reading demand against regulatory friction.
The HealthSpan Index synthesises the research and regulatory record together with Find My Chemist's proprietary data and analysis into one structured view — keeping the scientific and regulatory stream strictly separate from social conversation, and products separate from therapies.
Counts reflect research and regulatory activity, not efficacy, safety, or endorsement.
The HealthSpan Index is currently in private beta. Request access and we'll be in touch.
Descriptive market intelligence, not medical, investment, or regulatory advice.